Mucormycosis is a life-threatening fungal infection whose incidence has been rising recently, mainly due to the increasing use of immunosuppressive and corticosteroid treatment. In previous decades, mucormycosis was associated with a very poor prognosis as mortality was approximately 100%. Mortality rates reported in recent literature have only slightly improved despite the availability of targeted therapy with amphotericin B. Pulmonary mucormycosis is characteristically encountered in severely immunocompromised hosts, while rhino-orbital disease is often seen in individuals with diabetes mellitus. We report a rare case of fulminant pulmonary mucormycosis as an exceptionally rare complication of corticosteroid treatment in a 76-year-old patient with chronic obstructive pulmonary disease (COPD) and diabetes. The patient had presented with typical symptoms of an infective COPD exacerbation. The interesting aspects of our case were the absence of malignancy or immunosuppression, the isolation of Rhizomucor species, and the fungal invasion of the pleura and pericardium. Unfortunately, our patient died on the 49th day of hospitalisation, despite appropriate treatment.
Clinical examination revealed tachycardia, use of accessory muscles, pursed lip breathing, a prolonged expiratory phase and reduced breath sounds on the left side. The patient was febrile with a Glasgow Coma Scale of 15/15, heart rate of 166 beats per minute and blood pressure of 120/85 mmHg. Initial investigations showed an elevated white blood cell (WBC) count of 25×10 9 (neutrophilia) and a C-reactive protein (CRP) of 143 mg/l.
Methods and Procedures
The admission chest x-ray revealed consolidation in the left lower zone and blunting of the left costophrenic angle (Fig. 1) . Intravenous piperacillin/tazobactam and ciprofloxacin were commenced due to recent hospital admissions (no known colonisations), followed by meropenem and vancomycin due to clinical deterioration. Further chest x-rays demonstrated cavity formation (Fig. 2) . A chest CT scan revealed multiple cavities, especially in the left lower lobe, and a left-sided pleural effusion (Fig. 3) . Bronchoscopy showed copious purulent secretions and bronchial mucosa inflammation, especially at LC2 and LB6. Sputum and bronchial washing cultures isolated a mould that grew rapidly on Sabouraud dextrose agar (SDA) 2% at 37°C. The colony texture was cotton-candy like, velvety to floccose, with a white colour initially which, in time, turned yellowish-brown (Fig. 4) . Microscopic examination in lactophenol cotton blue stain revealed long and hyaline hyphae, stolons that were not fully developed, and a few rhizoids of different sizes on stolons, between the sporangiophores (Fig. 5) .
Sporangiophores were hyaline, simply branched, smooth-walled, variable and mostly subspherical. Sporangia were spherical with easily rupturing membranes and spherical columella. These findings were indicative of Rhizomucor species. The species grew on SDA 2% at 28°C, 37°C and 42°C. The isolate was also cultivated on potato dextrose agar (PDA) to obtain sporulation. For complete identification to subspecies level, the most appropriate method is polymerase chain reaction (PCR), but this is not currently available in our laboratory for moulds. Blood and pleural fluid cultures were negative. Serum galactomannan antigen was negative. Bronchial washing cytology and bronchial biopsies were negative for malignancy. A rhino-orbital CT scan was normal. An echocardiogram demonstrated an ejection fraction of 50% and pericardial effusion (1.3 cm), with no valve disease. Amphotericin B was commenced (on day 19). The patient's clinical course was complicated by pseudomembranous colitis, malnutrition and a hospital-acquired pneumonia (Klebsiella oxytoca and Pseudomonas aeruginosa isolated in subsequent sputum cultures). Despite appropriate antibiotic treatment, the patient died on the 49th day of hospitalization. DISCUSSION Mucormycosis (previously zygomycosis) is a rare fungal infection that has been increasing in frequency in recent years [1] [2] [3] [4] [5] . It is caused by fungi in the order of Mucorales, with most cases attributed to the genera of Rhizopus, Mucor, Lichtheimia and Rhizomucor [1] [2] [3] [4] [5] . These organisms are abundant in the environment, such as the soil and decaying matter. If inhaled, they can invade the tissues of susceptible patients. Having a strong affinity for vascular invasion, they can cause tissue necrosis and are thus associated with rapid disease progression and a high mortality rate [1] . Immunodeficiency, as in haematological malignancies and stem cell or solid organ transplantations, is the principal predisposing factor [1] [2] [3] [4] [5] . Other conditions associated with mucormycosis include diabetes mellitus, trauma, burns, prematurity, corticosteroids, aplastic anaemia, iron overload, malnutrition, intravenous drug abuse, human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infection [1] [2] [3] [4] [5] . There is no apparent age, sex or racial predilection. The typical sites of infection are rhino-orbito-cerebral, pulmonary, cutaneous and disseminated disease [1] [2] [3] [4] [5] .
The incidence is difficult to determine as it is not a notifiable disease and the risk differs amongst populations. Between 2005 and 2007, a total of 230 possible cases were noted [5] . Of these, 28 were attributed to Rhizomucor species. The principal host defence mechanism against the Mucorales fungi are the mononuclear and polymorphonuclear phagocytes, which produce cationic peptide defensins and generate oxidative metabolites [2] . High plasma glucose levels and acidosis, as in diabetes mellitus, reduce the ability of these phagocytes [2] . Acidosis is also associated with elevated serum iron levels, leading to rapid fungal proliferation [2] . Damage to endothelial cells leads to angioinvasion, vessel thrombosis, tissue necrosis and dissemination of the fungus. There is evidence that corticosteroid therapy causes functional defects in circulating neutrophils and impairs the role of bronchoalveolar macrophages in preventing spore germination following nasal inoculation [2] . 
